Korea Union Pharm "Vitamin C IV Injections Inquiries Flooded Due to COVID-19"

[Asia Economy Reporter Park Hyungsoo] Recently, as the number of confirmed cases of the novel coronavirus infection (COVID-19) has surged, interest in vitamin C injections has also increased.

According to the related industry on the 4th, Korea Union Pharmaceutical has been receiving inquiries about the vitamin C injection 'Cicovic Injection (Ascorbic Acid)'.

Korea Union Pharmaceutical's affiliate, Osco Korea Pharmaceutical, is currently producing and selling 'Ocovic Injection (Ascorbic Acid)'. Consumer inquiries and demand are gradually increasing.

Recently, vitamin C injections have been known to help prevent COVID-19 or improve the prognosis of patients with acute respiratory infections, which is believed to have led to the increase in inquiries, according to Korea Union Pharmaceutical. Formal clinical trials have started since last month, centered around Zhongnan Hospital in China.

Vitamin C is an essential nutrient in the body and an antioxidant nutrient that protects cells from harmful reactive oxygen species. It is an important nutrient that helps boost immunity, the body's defense system that recognizes and removes foreign substances within the human body.

When exposed to viruses, individual conditions vary depending on immunity, and if immunity weakens, the body's immune function cannot provide sufficient defense. Complications may develop during viral infections, leading to slower recovery. Maintaining vitamin C levels in the body while enhancing immunity is effective in disease prevention, according to a Korea Union Pharmaceutical official.

This content was produced with the assistance of AI translation services.